Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
TELA — TELA Bio, Inc.
NASDAQ
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 13, 2025
REVENUE
$20.7M +2.4%
NET MARGIN
-41.6% +7.5 PTS
EPS
-$0.19 +13.6%
FREE CASH FLOW
-$5.9M +26.1%

No summary has been written for this call yet.